Randomized Control Trial of Intravenous Acetaminophen (OFIRMEV) for the Reduction of Intrapartum Maternal Fever and Fetal Tachycardia

Trial Profile

Randomized Control Trial of Intravenous Acetaminophen (OFIRMEV) for the Reduction of Intrapartum Maternal Fever and Fetal Tachycardia

Recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Dec 2016

At a glance

  • Drugs Paracetamol (Primary) ; Paracetamol
  • Indications Fever
  • Focus Therapeutic Use
  • Acronyms RIFIVA
  • Most Recent Events

    • 14 Dec 2016 Status changed from not yet recruiting to recruiting.
    • 03 Oct 2016 Planned initiation date changed from 1 Feb 2016 to 1 Nov 2016.
    • 11 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top